| 靶点: |
TSHR |
| 体内研究: |
TSHR antagonist S37a also inhibits cyclic adenosine monophosphate formation by oligoclonal TSAb, which are highly enriched in GO patients' sera. TSHR antagonist S37a (10 mg/kg ;i.g.) displays no toxicity and a remarkable 53% oral bioavailability in mice. |
| 参考文献: |
1. Marcinkowski P, et al. A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' Orbitopathy. Thyroid. 2019 Jan;29(1):111-123. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.171 ml |
10.856 ml |
21.712 ml |
| 5 mM |
0.434 ml |
2.171 ml |
4.342 ml |
| 10 mM |
0.217 ml |
1.086 ml |
2.171 ml |
| 50 mM |
0.043 ml |
0.217 ml |
0.434 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |